Transforming biopharma at scale: A new operating model for life sciences with connected data and Agentic AI - IBM

IBM describes how AI and data management could transform pharmaceutical and life sciences companies. This is industry-focused and may impact drug development timelines, but the details are largely corporate positioning rather than concrete news.